Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk Prediction of Partial Ciliary Block After Phacoemulsification Combined With Goniosynechialysis in Primary Angle-Closure Disease: A Prospective Multicenter Study

NCT07549438 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT07549438
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07549438 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk Prediction of Partial Ciliary Block After Phacoemulsification Combined With Goniosynechialysis in Primary Angle-Closure Disease: A Prospective Multicenter Study
Lead sponsor
Peking University People's Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
April 20, 2026
Completion date
April 19, 2031
Enrollment
1,150 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

primary angle-closure glaucoma